Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series
Coronavirus disease 2019 (COVID-19) has infected more than 4.4 million people and caused more than 300,000 deaths partly through acute respiratory distress syndrome with propensity to affect African American and Hispanic communities disproportionately. Patients with worse outcomes have exhibited hig...
Saved in:
Published in | American journal of therapeutics Vol. 27; no. 5; p. e485 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.09.2020
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Coronavirus disease 2019 (COVID-19) has infected more than 4.4 million people and caused more than 300,000 deaths partly through acute respiratory distress syndrome with propensity to affect African American and Hispanic communities disproportionately. Patients with worse outcomes have exhibited higher blood plasma levels of proinflammatory cytokines. Activation of the vitamin D receptor expressed on immune cells has been shown to directly reduce the secretion of inflammatory cytokines, such as interleukin-6, and indirectly affect C-reactive protein.
The significance of the vitamin D pathway in patients diagnosed with COVID-19.
Vitamin D supplementation in patients after diagnosis of COVID-19.
We report 4 vitamin D deficient patients diagnosed with COVID-19 in April 2020 who were provided with either cholecalciferol of 1000 IU daily (standard dose) or ergocalciferol 50,000 IU daily for 5 days (high dose) as part of supplementation.
Patients that received a high dose of vitamin D supplementation achieved normalization of vitamin D levels and improved clinical recovery evidenced by shorter lengths of stay, lower oxygen requirements, and a reduction in inflammatory marker status.
Vitamin D supplementation may serve as a viable alternative for curtailing acute respiratory distress syndrome in patients in underserved communities where resources to expensive and sought-after medications may be scarce. Randomized clinical trials will serve as an appropriate vessel to validate the efficacy of the therapeutic regimen and dissection of the pathway. |
---|---|
AbstractList | Coronavirus disease 2019 (COVID-19) has infected more than 4.4 million people and caused more than 300,000 deaths partly through acute respiratory distress syndrome with propensity to affect African American and Hispanic communities disproportionately. Patients with worse outcomes have exhibited higher blood plasma levels of proinflammatory cytokines. Activation of the vitamin D receptor expressed on immune cells has been shown to directly reduce the secretion of inflammatory cytokines, such as interleukin-6, and indirectly affect C-reactive protein.
The significance of the vitamin D pathway in patients diagnosed with COVID-19.
Vitamin D supplementation in patients after diagnosis of COVID-19.
We report 4 vitamin D deficient patients diagnosed with COVID-19 in April 2020 who were provided with either cholecalciferol of 1000 IU daily (standard dose) or ergocalciferol 50,000 IU daily for 5 days (high dose) as part of supplementation.
Patients that received a high dose of vitamin D supplementation achieved normalization of vitamin D levels and improved clinical recovery evidenced by shorter lengths of stay, lower oxygen requirements, and a reduction in inflammatory marker status.
Vitamin D supplementation may serve as a viable alternative for curtailing acute respiratory distress syndrome in patients in underserved communities where resources to expensive and sought-after medications may be scarce. Randomized clinical trials will serve as an appropriate vessel to validate the efficacy of the therapeutic regimen and dissection of the pathway. |
Author | Ohaegbulam, Kim C Perrin, Richard Patel, Pranavkumar Smith, Miriam A Swalih, Mohamed |
Author_xml | – sequence: 1 givenname: Kim C surname: Ohaegbulam fullname: Ohaegbulam, Kim C organization: Department of Medicine, Long Island Jewish Forest Hills Hospital, Forest Hills, NY – sequence: 2 givenname: Mohamed surname: Swalih fullname: Swalih, Mohamed – sequence: 3 givenname: Pranavkumar surname: Patel fullname: Patel, Pranavkumar – sequence: 4 givenname: Miriam A surname: Smith fullname: Smith, Miriam A – sequence: 5 givenname: Richard surname: Perrin fullname: Perrin, Richard |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32804682$$D View this record in MEDLINE/PubMed |
BookMark | eNpNj11LwzAYhYMo7kP_gUj-QLZ8N_VudJtuTCZs7nYky1uItFlpugv_vRUVPDcHngcOnBG6jucICD0wOmE0z6av6_2E_gvjnF-hIVNCE6GNHqBRSh_f3DB5iwaCGyq14UO0PITO1iHiOd5dmqaCGmJnu3COuIfF9rCaE5bjtx71Ij3hGS6qEMPJVriwCfAO2gDpDt2Utkpw_9tj9L5c7IsXstk-r4rZhpykyjvChcipMK500nihBXU-o9oq7qGk3hhg2mqZgZUenBTSKCWdUlmuveDeKz5Gjz-7zcXV4I9NG2rbfh7_DvEvtdRLhw |
CitedBy_id | crossref_primary_10_3389_fpubh_2020_613462 crossref_primary_10_3390_nu12113361 crossref_primary_10_1007_s12020_022_03203_8 crossref_primary_10_3390_ijerph18020740 crossref_primary_10_1186_s12859_023_05479_7 crossref_primary_10_7762_cnr_2023_12_1_77 crossref_primary_10_3389_fendo_2021_644298 crossref_primary_10_14814_phy2_15592 crossref_primary_10_1136_rmdopen_2020_001454 crossref_primary_10_1016_j_ijid_2020_10_059 crossref_primary_10_3390_cells9122679 crossref_primary_10_3390_nu13103458 crossref_primary_10_1093_advances_nmab031 crossref_primary_10_2217_fmb_2021_0064 crossref_primary_10_1097_TIN_0000000000000284 crossref_primary_10_1111_1756_185X_14477 crossref_primary_10_1080_07315724_2020_1869626 crossref_primary_10_1016_j_ctim_2021_102788 crossref_primary_10_1097_MNH_0000000000000723 crossref_primary_10_3390_ijms221910559 crossref_primary_10_1007_s41970_021_00146_w crossref_primary_10_1093_advances_nmab128 crossref_primary_10_3390_ijerph19010447 crossref_primary_10_3390_nu13030976 crossref_primary_10_3390_v14081774 crossref_primary_10_32322_jhsm_1063405 crossref_primary_10_5497_wjp_v10_i1_1 crossref_primary_10_1016_j_biopha_2022_112965 crossref_primary_10_1002_ptr_8096 crossref_primary_10_1080_00325481_2021_2017647 crossref_primary_10_3390_nu14122447 crossref_primary_10_1016_j_intimp_2020_107001 crossref_primary_10_1002_ccr3_4010 crossref_primary_10_3389_fphar_2022_863587 crossref_primary_10_4236_aid_2023_133037 crossref_primary_10_3390_nu16101402 crossref_primary_10_14218_ERHM_2020_00059 crossref_primary_10_1016_j_eclinm_2021_100967 crossref_primary_10_1016_j_clnesp_2021_11_003 crossref_primary_10_1038_s41598_021_85809_y crossref_primary_10_3389_fnut_2022_834826 crossref_primary_10_1080_14787210_2021_1905519 crossref_primary_10_2147_IJGM_S309003 crossref_primary_10_3389_fphys_2020_564387 crossref_primary_10_20960_nh_03731 crossref_primary_10_3390_nu13103596 crossref_primary_10_1136_bmjopen_2021_057024 crossref_primary_10_1016_j_trim_2021_101374 crossref_primary_10_18231_j_ijcbr_2021_038 crossref_primary_10_1016_j_jcm_2021_12_005 crossref_primary_10_3390_nu13072170 crossref_primary_10_14710_jnc_v12i1_33167 crossref_primary_10_3390_cells12071092 crossref_primary_10_1007_s11010_021_04245_8 crossref_primary_10_3390_nu13030717 crossref_primary_10_15406_ipmrj_2023_08_00324 crossref_primary_10_35366_101309 crossref_primary_10_3390_nu12113512 crossref_primary_10_3389_fimmu_2021_758154 crossref_primary_10_1016_j_ijid_2020_12_077 crossref_primary_10_14302_issn_2474_7785_jarh_20_3650 crossref_primary_10_3390_medicina58070941 crossref_primary_10_2174_1381612828666220418132847 crossref_primary_10_1097_MD_0000000000024517 crossref_primary_10_1111_bcpt_13872 crossref_primary_10_3390_nu12123741 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1097/MJT.0000000000001222 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1536-3686 |
ExternalDocumentID | 32804682 |
Genre | Journal Article |
GroupedDBID | --- .Z2 0R~ 23M 354 4Q1 4Q2 4Q3 53G 5GY 5VS 6J9 71W 8L- AAAAV AAHPQ AAIQE AARTV AASCR AAWTL AAYOK ABASU ABBUW ABDIG ABJNI ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFS ACILI ACNWC ACWDW ACWRI ACXJB ACXNZ ADFPA ADGGA ADHPY ADNKB AE3 AEETU AENEX AFDTB AHQNM AHVBC AINUH AJIOK AJNWD AJNYG ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BQLVK BS7 C45 CAG CGR COF CS3 CUY CVF DIWNM DUNZO E.X EBS ECM EEVPB EIF EJD EX3 F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ IPNFZ JF9 JG8 JK3 JK8 K8S KD2 L-C NPM N~M O9- OAG OAH OCUKA ODA OHH OJAPA OLG OLW OPUJH ORVUJ OUVQU OVD OVDNE OWU OWV OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W XXN XYM YFH ZFV ZZMQN |
ID | FETCH-LOGICAL-c459t-2339038bfb48d3630bd706a52def0d88e16a647ea4deb4348554b55796d32dd52 |
IngestDate | Thu May 23 23:35:15 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c459t-2339038bfb48d3630bd706a52def0d88e16a647ea4deb4348554b55796d32dd52 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473790 |
PMID | 32804682 |
ParticipantIDs | pubmed_primary_32804682 |
PublicationCentury | 2000 |
PublicationDate | 2020-09-01 |
PublicationDateYYYYMMDD | 2020-09-01 |
PublicationDate_xml | – month: 09 year: 2020 text: 2020-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of therapeutics |
PublicationTitleAlternate | Am J Ther |
PublicationYear | 2020 |
SSID | ssj0012814 |
Score | 2.5091183 |
Snippet | Coronavirus disease 2019 (COVID-19) has infected more than 4.4 million people and caused more than 300,000 deaths partly through acute respiratory distress... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | e485 |
SubjectTerms | Adult Betacoronavirus - isolation & purification C-Reactive Protein - analysis Cholecalciferol - administration & dosage Comorbidity Coronavirus Infections - blood Coronavirus Infections - diagnosis Coronavirus Infections - epidemiology Coronavirus Infections - therapy COVID-19 Dietary Supplements Ergocalciferols - administration & dosage Female Humans Length of Stay - statistics & numerical data Male Middle Aged Oxygen Inhalation Therapy - methods Oxygen Inhalation Therapy - statistics & numerical data Pandemics Pneumonia, Viral - blood Pneumonia, Viral - diagnosis Pneumonia, Viral - epidemiology Pneumonia, Viral - therapy Receptors, Calcitriol - metabolism SARS-CoV-2 Treatment Outcome Vitamin D Deficiency - diagnosis Vitamin D Deficiency - drug therapy Vitamin D Deficiency - epidemiology Vitamin D Deficiency - metabolism Vitamins - administration & dosage |
Title | Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32804682 |
Volume | 27 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFLYKkxCXiXU_2IDJB8QFMhrbSWxuqB3qigI9FMQN2bEDFUrhUIbgyj_Oc2yXqDAJ1kNU2VIU-fv8_Pz83meENpU2CuYYjURSiojpQkecS-ByUZJCC1awWnYxP0r7J2xwlpy1Wo-NrKXbqfpVPLxaV_I_qEIb4GqrZN-B7Oyl0AD_AV94AsLwfBPGp7Cxr8aT7d52fTmnSwQP2Yvd49M_vSgWVoV_XKdLuCL0UArZhfXLmoqQRRikaMMRTkNTolGkNXPBjy-luVC3nlCH46oRb70D574O1-TXl7Ly5VP1OdXUJQUMYYWUf69seveLEE8-hpGrfIzVxyNg8xkSrmA5CTY0jWjqFa69kXUCAJ5MScNiGuau7Hlhyp1EcD4YOYlJ_4uJK2NuoHtT1fBSwmGvz9_QOyewHboW0ELGrZE8sgEffxBFeMxCxaXIdl_7nGW0FF4xtzepfZTRCvroNxd43zHlE2qZSRst5T59oo22hk6o_H4HjxqQ7uAtPHyWML__jA48s3APzzELQ2NgFg7M2sP7OPAKW15hx6sv6OTg96jbj_yNG1HBEjGNCKWiQ7kqFeOaprSjdNZJZUK0KTuacxOnMmWZkQymOKNWWIipxJYza0q0TshXtDi5nphVhDMN3qMRYAvKhJGskEKyrFBGqrgUjJjv6JsbqvMbJ6tyHgbxxz971tDyM-PW0YcS5rHZAKdwqn7WsD0B3_1dTg |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vitamin+D+Supplementation+in+COVID-19+Patients%3A+A+Clinical+Case+Series&rft.jtitle=American+journal+of+therapeutics&rft.au=Ohaegbulam%2C+Kim+C&rft.au=Swalih%2C+Mohamed&rft.au=Patel%2C+Pranavkumar&rft.au=Smith%2C+Miriam+A&rft.date=2020-09-01&rft.eissn=1536-3686&rft.volume=27&rft.issue=5&rft.spage=e485&rft_id=info:doi/10.1097%2FMJT.0000000000001222&rft_id=info%3Apmid%2F32804682&rft_id=info%3Apmid%2F32804682&rft.externalDocID=32804682 |